John Maynard Conly
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 0.2%
- Antimicrobial Resistance in Staphylococcus
- Infection Control in Healthcare
- COVID-19 Clinical Research Studies
Papers in
-
- Antimicrobial Resistance in Staphylococcus 66
- Infection Control in Healthcare 38
- SARS-CoV-2 and COVID-19 Research 18
- COVID-19 Clinical Research Studies 15
-
- Antibiotic Use and Resistance 70
- Co-authors
- Kunyan Zhang (32 shared papers)Thomas Louie (22 shared papers)Sameer Elsayed (14 shared papers)Jo-Ann McClure-Warnier (24 shared papers)Melissa Severn (3 shared papers)Karen Cimon (3 shared papers)Khai Trieu Tran (3 shared papers)Carmem Lúcia Pessoa-Silva (3 shared papers)
- Journals
- Infection Control and Hospital Epidemiology (28 papers)Antimicrobial Resistance and Infection Control (18 papers)Clinical Infectious Diseases (13 papers)F1000Research (10 papers)Canadian Journal of Infectious Diseases and Medical Microbiology (87 papers)
- Partner nations
- CanadaUnited KingdomSwitzerland
In The Last Decade
John Maynard Conly
381 papers receiving 14.3k citations
John Maynard Conly's Hit Papers
Peers
Comparison fields: 5 of 189
- Applied Microbiology and Biotechnology 1.3k
- Infectious Diseases 5.2k
- Molecular Medicine 1.4k
- General Dentistry 70
- Emergency Medical Services 613
Countries citing papers authored by John Maynard Conly
This map shows the geographic impact of John Maynard Conly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Maynard Conly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Maynard Conly more than expected).
Fields of papers citing papers by John Maynard Conly
This network shows the impact of papers produced by John Maynard Conly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Maynard Conly. The network helps show where John Maynard Conly may publish in the future.
Co-authors
The 25 scholars most cited alongside John Maynard Conly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 404 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Aerosol Generating Procedures and Risk of Transmission of Acute Respiratory Infections to Healthcare Workers: A Systematic Review Hit paper breakdown → | 2012 | 1364 |
| 2 | Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo Hit paper breakdown → | 2012 | 990 |
| 3 | Novel Multiplex PCR Assay for Characterization and Concomitant Subtyping of Staphylococcal Cassette ChromosomemecTypes I to V in Methicillin-ResistantStaphylococcus aureus Hit paper breakdown → | 2005 | 933 |
| 4 | Physical interventions to interrupt or reduce the spread of respiratory viruses Hit paper breakdown → | 2011 | 650 |
| 5 | Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey Hit paper breakdown → | 2018 | 526 |
| 6 | Carbapenemase-Producing Organisms: A Global Scourge Hit paper breakdown → | 2017 | 503 |
| 7 | 2006 | 341 | |
| 8 | 2004 | 301 | |
| 9 | Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses Hit paper breakdown → | 2022 | 290 |
| 10 | 2018 | 276 | |
| 11 | 2016 | 271 | |
| 12 | 2020 | 228 | |
| 13 | 1989 | 226 | |
| 14 | 2016 | 211 | |
| 15 | 1997 | 198 | |
| 16 | Physical interventions to interrupt or reduce the spread of respiratory viruses Hit paper breakdown → | 2023 | 175 |
| 17 | 2008 | 160 | |
| 18 | 1989 | 158 | |
| 19 | 2022 | 154 | |
| 20 | 2003 | 152 |
About John Maynard Conly
John Maynard Conly is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology, Molecular Medicine, Pulmonary and Respiratory Medicine and Epidemiology, having authored 404 papers that have together received 15.1k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (70 papers), Antimicrobial Resistance in Staphylococcus (66 papers), Infection Control and Ventilation (44 papers), Infection Control in Healthcare (38 papers), Antibiotic Resistance in Bacteria (30 papers), SARS-CoV-2 and COVID-19 Research (18 papers), COVID-19 Clinical Research Studies (15 papers) and COVID-19 epidemiological studies (13 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (1.3k citations), Infectious Diseases (5.2k citations), Molecular Medicine (1.4k citations), General Dentistry (70 citations) and Emergency Medical Services (613 citations). John Maynard Conly has collaborated with scholars based in Canada, United Kingdom and Switzerland. Frequent co-authors include Kunyan Zhang, Thomas Louie, Sameer Elsayed, Jo-Ann McClure-Warnier, Melissa Severn, Karen Cimon, Khai Trieu Tran, Carmem Lúcia Pessoa-Silva, BL Johnston and Tom Jefferson. Their work appears in journals such as Infection Control and Hospital Epidemiology, Antimicrobial Resistance and Infection Control, Clinical Infectious Diseases, F1000Research and Canadian Journal of Infectious Diseases and Medical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.